Research output per year
Research output per year
Personal profile
Academic discipline
MEDS-01/A - Medical Genetics
Fingerprint
Dive into the research topics where Elisabetta Tabolacci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
A mechanistic framework for somatic mosaicism in autoinflammatory diseases beyond Mendelian inheritance
Krishnakumar, A., Tabolacci, E. & Rigante, D., 2026, In: International Journal of Molecular Sciences. 2026, 27(19): 8554, p. 1-19 19 p.Research output: Contribution to journal › Article
-
FMR1 RNA int er action with DNMT1 blocks DNA methylation at the FMR1 locus
Nobile, V., Niccolini, B., Pucci, C., Pietrobono, R., Modafferi, C., Esposito, C. L., Cappoli, N., Bianchetti, G., Maulucci, G., Aceto, G., D'Ascenzo, M., Chiurazzi, P., Dello Russo, C., Genuardi, M., Neri, G., Di Ruscio, A. & Tabolacci, E., 2026, In: NAR MOLECULAR MEDICINE. 3, 1, p. N/A.-N/A.Research output: Contribution to journal › Article
-
Genetic Determinants of Primary Failure of Eruption: A Comprehensive Review of PTH1R Variants
Niccolini, B., Lauretti, G., Chiurazzi, P., Grippaudo, C. & Tabolacci, E., 2026, In: Genes. 2026, 17, p. 1-14 14 p.Research output: Contribution to journal › Article › peer-review
-
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity
Petito, V., Gerovska, D., Piazzesi, A., Di Vincenzo, F., Russo, A., Turchini, L., Masi, L., Emoli, V., Tabolacci, E., Giustiniani, M. C., Mazza, T., Laterza, L., Papa, A., Lopetuso, L. R., Putignani, L., Gasbarrini, A., Araúzo-Bravo, M. J. & Scaldaferri, F., 2026, In: Journal of Crohn's and Colitis. 20, 2, p. N/A-N/AResearch output: Contribution to journal › Article
-
NLRP12 as a regulator of inflammation: insights into the correlation with autoinflammatory disorders
Rosa, B., Tabolacci, E., Pietrobono, R., Sangiorgi, E., Gurrieri, F., Chiurazzi, P., Sicignano, L. L., Verrecchia, E., Genuardi, M., Rigante, D. & Manna, R., 2026, In: Genes. 2026, 17(4): 421, p. 1-13 13 p.Research output: Contribution to journal › Article
Datasets
-
MOESM8 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Palumbo, F. (Creator), Neri, G. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Goracci, M. (Creator), Ferrè, F. (Contributor) & Helmer-Citterich, M. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3641399_d8.v1, https://figshare.com/articles/MOESM8_of_Genome-wide_methylation_analysis_demonstrates_that_5-aza-2-deoxycytidine_treatment_does_not_cause_random_DNA_demethylation_in_fragile_X_syndrome_cells/4459022/1
Dataset
-
Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Palumbo, F. (Creator), Goracci, M. (Creator), Ferrè, F. (Creator), Helmer-Citterich, M. (Creator) & Neri, G. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3641399, https://figshare.com/collections/Genome-wide_methylation_analysis_demonstrates_that_5-aza-2-deoxycytidine_treatment_does_not_cause_random_DNA_demethylation_in_fragile_X_syndrome_cells/3641399
Dataset
-
MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Palumbo, F. (Creator), Goracci, M. (Creator), Ferrè, F. (Contributor), Helmer-Citterich, M. (Creator) & Neri, G. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3641399_d1, https://springernature.figshare.com/articles/dataset/MOESM7_of_Genome-wide_methylation_analysis_demonstrates_that_5-aza-2-deoxycytidine_treatment_does_not_cause_random_DNA_demethylation_in_fragile_X_syndrome_cells/4459001
Dataset
-
MOESM7 of Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Palumbo, F. (Creator), Goracci, M. (Creator), Ferrè, F. (Contributor), Helmer-Citterich, M. (Creator) & Neri, G. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3641399_d1.v1, https://springernature.figshare.com/articles/dataset/MOESM7_of_Genome-wide_methylation_analysis_demonstrates_that_5-aza-2-deoxycytidine_treatment_does_not_cause_random_DNA_demethylation_in_fragile_X_syndrome_cells/4459001/1
Dataset
-
Genome-wide methylation analysis demonstrates that 5-aza-2-deoxycytidine treatment does not cause random DNA demethylation in fragile X syndrome cells
Tabolacci, E. (Creator), Mancano, G. (Creator), Lanni, S. (Creator), Palumbo, F. (Creator), Goracci, M. (Creator), Ferrè, F. (Creator), Helmer-Citterich, M. (Creator) & Neri, G. (Creator), figshare, 2016
DOI: 10.6084/m9.figshare.c.3641399.v1, https://figshare.com/collections/Genome-wide_methylation_analysis_demonstrates_that_5-aza-2-deoxycytidine_treatment_does_not_cause_random_DNA_demethylation_in_fragile_X_syndrome_cells/3641399/1
Dataset